Compare Essex Property Trust, Inc. (ESS) vs Pfizer Inc (PFE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Essex Property Trust, Inc. vs Pfizer Inc — how do they compare? Essex Property Trust, Inc. trades at $272.96 (market cap $17.26B), while Pfizer Inc trades at $28.16 (market cap $158.56B). The key difference: Pfizer Inc is far larger — about 9.2× Essex Property Trust, Inc.'s market cap, and Pfizer Inc pays the higher dividend (6.18%). Which is the better fit depends on your goals — on Pluang, investors hold Essex Property Trust, Inc. for 111 Days and Pfizer Inc for 158 Days on average.
| ESS | PFE | |
|---|---|---|
Market Cap | $17.26B | $158.56B |
Volume | 454,464 | 44,138,282 |
Sector | Real Estate | Health |
52-Week High | $298.33 | $29.02 |
52-Week Low | $239.61 | $23.67 |
Typical Hold Time | 111 Days | 158 Days |
Enterprise Value | $23.86B | $210.06B |
Dividend Yield | 3.86% | 6.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ESS trades at $270.20, up 0.8% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong Q2 2026 results beating FFO guidance and raised full-year outlook, though recent earnings show volatility with two misses in the last four quarters. Revenue has grown steadily from $1.6B in 2022 to $1.9B in 2025, while profit margins remain healthy at 35.48%.
The stock presents a compelling opportunity with 18 buy ratings and consensus price target of $303.41 (12.3% upside), supported by strong operational performance and litigation resolution. Key risks include elevated valuation multiples (P/E 41.83) and debt levels, while institutional buying from BlackRock and Canada Pension Plan provides confidence in the recovery thesis.
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Essex Property Trust, Inc.
Essex Property Trust owns a portfolio of 253 apartment communities with over 62,000 units and is developing three additional properties with 571 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
Read more on ESS →About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →
